Intellia Therapeutics, Inc. ($NTLA)
Clark Eliana โ EVP, Chief Technical Officer
Shares
7,353
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.99
Revenue:Est: $12.17M
Transaction Details
| Insider | Clark Eliana |
|---|---|
| Title | EVP, Chief Technical Officer |
| Transaction Date | Mar 1, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Purchased | 7,353 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 94,471 |
| Derivative | No |
| Accession Number | 0001193125-26-088241 |
| Document | View SEC Filing |